The Union Health Ministry in India has proposed significant new restrictions on the advertising of prescription medicines. These measures aim to bring drug retailers, wholesalers, and distributors under the same stringent advertising framework currently applied only to pharmaceutical manufacturers.
New Rules Target Retailers and Wholesalers
Under the proposed amendment to the Drugs Rules, 1945, any advertisement for medicines listed under Schedule H, Schedule H1, and Schedule X will require prior approval from the Central government. This marks a crucial expansion of existing regulations.
Currently, manufacturers of these specific categories of drugs cannot advertise them without prior government sanction. The government noted that the existing provisions did not explicitly cover entities involved in the retail and wholesale sale and distribution of these medicines, creating a loophole that the new draft rules seek to close.
The proposed rule would apply to holders of licences to sell, stock, exhibit or offer drugs for sale, as well as those involved in their distribution. This would extend the advertising restriction to retailers, wholesalers and distributors of these medicines.
Why the Change?
The primary motivation behind these tighter rules is to reduce the risks associated with inappropriate self-medication. By reinforcing safeguards around medicines that require strict medical supervision—including certain antibiotics, psychotropic medicines, and other prescription-only drugs—the government aims to protect public health.
This proposal follows recommendations made by the Drugs Technical Advisory Board (DTAB) during its 93rd meeting held on February 16, 2026. The board specifically addressed the necessity for provisions governing advertisements by entities holding drug sale and distribution licenses.
What Happens Next?
The proposal is currently in its draft stage. The Health Ministry has invited objections and suggestions from all stakeholders and the general public. There is a 30-day window from the date the Gazette containing the draft rules was made available for submissions. The government will carefully consider all feedback before deciding whether to finalize the amendment.
If finalized, these updated rules will come into force from the date of their official publication in the Official Gazette. For pharmacies, wholesalers, and distributors, this change will introduce an additional compliance requirement for any promotional activities involving medicines covered under these three schedules.